{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:13:12Z","timestamp":1791000792811,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Province Science Foundation","doi-asserted-by":"publisher","award":["2016JJ2102"],"award-info":[{"award-number":["2016JJ2102"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009377","name":"open fund of Chinese Hunan Provincial Education Department innovation platform","doi-asserted-by":"publisher","award":["15K109"],"award-info":[{"award-number":["15K109"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2012M521528"],"award-info":[{"award-number":["2012M521528"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Science Foundation","doi-asserted-by":"publisher","award":["81172210"],"award-info":[{"award-number":["81172210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2019,10,15]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>&lt;P&gt;Aims: The aim is to study the role of miR-675-5p coded by long non-coding RNA H19 in the\ndevelopment of Nasopharyngeal Cancer (NPC) and whether miR-675-5p regulates the invasion and metastasis\nof NPC through targeting SFN (14-3-3&amp;#963;). The study further validated the relationship between H19,\nmiR-675-5p and SFN in NPC and their relationship with the invasion and metastasis of NPC.\n&lt;\/P&gt;&lt;P&gt;\nMethods: Western blot was used to detect the expression of 14-3-3&amp;#963; protein in immortalized normal nasopharyngeal\nepithelial cells NP69 and different metastatic potential NPC cells, 6-10B and 5-8F. At the same\ntime, to find out the relationship between 14-3-3&amp;#963; protein and the expression of H19 and miR-675-5p, the\nexpression of H19 and miR-675-5p in normal nasopharynx epithelial cells NP69 and varied nasopharyngeal\ncarcinoma cells 6-10B and 5-8F were quantified by real-time PCR. MiR-675-5p mimic and inhibitor\nwere transfected into NPC 6-10B to over-express and down-express miR-675-5p; miR-675-5p mimic\nnegative control and inhibitor negative control were transfected into NPC 6-10B as control groups. The\neffect of over-expression and down-expression by miR-675-5p on the expression of 14-3-3&amp;#963; protein was\ndetected by Western blotting. The 3\u2019-UTR segments of SFN, containing miR-675-5p binding sites were\namplified by PCR and the luciferase activity in the transfected cells was assayed to detect whether SFN is\nthe direct target of miR-675-5p. Transwell and scratch assays were used to verify the changes in NPC\ninvasion and metastasis ability of mimics and inhibitors transfected with miR-675-5p.\n&lt;\/P&gt;&lt;P&gt;\nResults: The expression of 14-3-3&amp;#963; protein in normal nasopharynx epithelial cells NP69 is significantly\nhigher than in varied nasopharyngeal carcinoma cells, 6-10B and 5-8F (P&lt;0.05), and the 14-3-3&amp;#963; protein\nlevels in low-metastatic nasopharyngeal carcinoma cell 6-10B is higher than in high-metastatic nasopharyngeal\ncarcinoma cell 5-8F. The expression of H19 and miR-675-5p are significantly higher in NPC\ncells than in NP69 cell (P&lt;0.05). The expression of H19 and miR-675-5p in high-Metastatic nasopharyngeal\ncarcinoma cell 5-8F was higher than in low-Metastatic nasopharyngeal carcinoma cell 6-10B. The\nexpression of 14-3-3&amp;#963; protein in miR-675-5p mimic cells was significantly lower than in mimic NC (negative\ncontrol) group and blank control group. However, compared with the blank control group, mimic NC\nshowed no significant difference in 14-3-3&amp;#963; protein between the two groups. The miR-675-5p inhibitor\ngroup was significantly higher than the inhibitor NC group and the blank control group (p&lt;0.05), but there\nwas no significant difference in the expression of 14-3-3&amp;#963; protein in the inhibitor NC group and the blank\ncontrol group (p&gt;0.05). Dual-luciferase reporter assay system shows the 3\u2019-UTR segments of SFN containing\nmiR-675-5p binding sites. SFN was the target gene of miR-675-5p.\n&lt;\/P&gt;&lt;P&gt;\nConclusion: 14-3-3&amp;#963; is downregulated in NPC and is involved in the development of NPC. H19 and miR-\n675-5p are upregulated in NPC, which is related to the development of NPC. The over-expression of miR-\n675-5p inhibits the expression of 14-3-3&amp;#963; protein. SFN is the target gene of miR-675-5p. MiR-675-5p\ntargets SFN, downregulates its protein expression and promotes the invasion and metastasis of NPC.&lt;\/P&gt;\n<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467212666190719120446","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T18:24:09Z","timestamp":1563992649000},"page":"324-333","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["H19\/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells"],"prefix":"10.1016","volume":"12","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Lei","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Xie","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Huang","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Huang","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tang","sequence":"additional","affiliation":[{"name":"Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gong","sequence":"additional","affiliation":[{"name":"Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Lin","sequence":"additional","affiliation":[{"name":"Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Huang","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Hengyang Medical College of University of South China, Hengyang 421001, Hunan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","first-page":"65","volume":"32","author":"Zong Y.","year":"2003","unstructured":"Zong Y.; Pathological study of NPC. Chinese Journal of Pathology 2003,32(1),65-68","journal-title":"Chinese Journal of Pathology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40880-018-0338-4","volume":"38","author":"Zou X.","year":"2018","unstructured":"Zou X.; Wang S.L.; Liu Y.P.; Liu Y.L.; Zou R.H.; Zhang Y.N.; You R.; Yang Q.; Xie Y.L.; Lin M.; Huang P.Y.; Jiang R.; Zhang M.X.; Qian C.N.; Mai H.Q.; Guo L.; Hong M.H.; Chen M.Y.; A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma. Cancer Commun (Lond) 2018,38(1),74","journal-title":"Cancer Commun (Lond)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clon.2012.10.006","volume":"25","author":"Colaco R.J.","year":"2013","unstructured":"Colaco R.J.; Betts G.; Donne A.; Swindell R.; Yap B.K.; Sykes A.J.; Slevin N.J.; Homer J.J.; Lee L.W.; Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol) 2013,25(3),171-177","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12859-018-2536-0","volume":"19","author":"Tran N.","year":"2018","unstructured":"Tran N.; Abhyankar V.; Nguyen K.; Weidanz J.; Gao J.; MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers. BMC Bioinformatics 2018,19(Suppl. 20),504","journal-title":"BMC Bioinformatics"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nature12946","volume":"505","author":"Wan Y.","year":"2014","unstructured":"Wan Y.; Qu K.; Zhang Q.C.; Flynn R.A.; Manor O.; Ouyang Z.; Zhang J.; Spitale R.C.; Snyder M.P.; Segal E.; Chang H.Y.; Landscape and variation of RNA secondary structure across the human transcriptome. Nature 2014,505(7485),706-709","journal-title":"Nature"},{"key":"ref=6","first-page":"5175","volume":"30","author":"Okumura H.","year":"2010","unstructured":"Okumura H.; Kita Y.; Yokomakura N.; Uchikado Y.; Setoyama T.; Sakurai H.; Omoto I.; Matsumoto M.; Owaki T.; Ishigami S.; Natsugoe S.; Nuclear expression of 14-3-3 \u03c3 is related to prognosis in patients with esophageal squamous cell carcinoma. Anticancer Res 2010,30(12),5175-5179","journal-title":"Anticancer Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3892\/ol.2014.2676","volume":"9","author":"Li Y.L.","year":"2015","unstructured":"Li Y.L.; Liu L.; Xiao Y.; Zeng T.; Zeng C.; 14-3-3\u03c3 is an independent prognostic biomarker for gastric cancer and is associated with apoptosis and proliferation in gastric cancer. Oncol Lett 2015,9(1),290-294","journal-title":"Oncol Lett"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/onc.2010.550","volume":"30","author":"Meng L.","year":"2011","unstructured":"Meng L.; Hsu J.K.; Tsai R.Y.; GNL3L depletion destabilizes MDM2 and induces p53-dependent G2\/M arrest. Oncogene 2011,30(14),1716-1726","journal-title":"Oncogene"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biocel.2009.10.001","volume":"42","author":"Huang W.G.","year":"2010","unstructured":"Huang W.G.; Cheng A.L.; Chen Z.C.; Peng F.; Zhang P.F.; Li M.Y.; Li F.; Li J.L.; Li C.; Yi H.; Li X.H.; Yi B.; Xiao Z.Q.; Targeted proteomic analysis of 14-3-3\u03c3 in nasopharyngeal carcinoma. Int J Biochem Cell Biol 2010,42(1),137-147","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1158\/1078-0432.CCR-07-1215","volume":"14","author":"Cheng A.L.","year":"2008","unstructured":"Cheng A.L.; Huang W.G.; Chen Z.C.; Peng F.; Zhang P.F.; Li M.Y.; Li F.; Li J.L.; Li C.; Yi H.; Yi B.; Xiao Z.Q.; Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res 2008,14(2),435-445","journal-title":"Clin Cancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jcb.22051","volume":"106","author":"Yi B.","year":"2009","unstructured":"Yi B.; Tan S.X.; Tang C.E.; Huang W.G.; Cheng A.L.; Li C.; Zhang P.F.; Li M.Y.; Li J.L.; Yi H.; Peng F.; Chen Z.C.; Xiao Z.Q.; Inactivation of 14-3-3 \u03c3 by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J Cell Biochem 2009,106(5),858-866","journal-title":"J Cell Biochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-015-0458-2","volume":"14","author":"Raveh E.","year":"2015","unstructured":"Raveh E.; Matouk I.J.; Gilon M.; Hochberg A.; The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory. Mol Cancer 2015,14(1),184","journal-title":"Mol Cancer"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"22513","DOI":"10.18632\/oncotarget.4154","volume":"6","author":"Liang W.C.","year":"2015","unstructured":"Liang W.C.; Fu W.M.; Wong C.W.; Wang Y.; Wang W.M.; Hu G.X.; Zhang L.; Xiao L.J.; Wan D.C.; Zhang J.F.; Waye M.M.; The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 2015,6(26),22513-22525","journal-title":"Oncotarget"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1159\/000480028","volume":"42","author":"Yan J.","year":"2017","unstructured":"Yan J.; Zhang Y.; She Q.; Li X.; Peng L.; Wang X.; Liu S.; Shen X.; Zhang W.; Dong Y.; Lu J.; Zhang G.; Long Noncoding RNA H19\/miR-675 Axis Promotes Gastric Cancer via FADD\/Caspase 8\/Caspase 3 Signaling Pathway. Cell Physiol Biochem 2017,42(6),2364-2376","journal-title":"Cell Physiol Biochem"},{"key":"ref=15","first-page":"5946","volume":"22","author":"Qian B.","year":"2018","unstructured":"Qian B.; Wang D.M.; Gu X.S.; Zhou K.; Wu J.; Zhang C.Y.; He X.Y.; LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107. Eur Rev Med Pharmacol Sci 2018,22(18),5946-5953","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1080\/15384101.2018.1482137","volume":"17","author":"Ren J.","year":"2018","unstructured":"Ren J.; Fu J.; Ma T.; Yan B.; Gao R.; An Z.; Wang D.; LncRNA H19-elevated LIN28B promotes lung cancer progression through sequestering miR-196b. Cell Cycle 2018,17(11),1372-1380","journal-title":"Cell Cycle"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/OTT.S149908","volume":"11","author":"Li J.","year":"2018","unstructured":"Li J.; Huang Y.; Deng X.; Luo M.; Wang X.; Hu H.; Liu C.; Zhong M.; Long noncoding RNA H19 promotes transforming growth factor-\u03b2-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells. OncoTargets Ther 2018,11,427-440","journal-title":"OncoTargets Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1002\/jcb.27669","volume":"120","author":"Sun Y.","year":"2019","unstructured":"Sun Y.; Zhu Q.; Yang W.; Shan Y.; Yu Z.; Zhang Q.; Wu H.; LncRNA H19\/miR-194\/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. J Cell Biochem 2019,120(3),3874-3886","journal-title":"J Cell Biochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3892\/ol.2015.3165","volume":"10","author":"Huang C.","year":"2015","unstructured":"Huang C.; Cao L.; Qiu L.; Dai X.; Ma L.; Zhou Y.; Li H.; Gao M.; Li W.; Zhang Q.; Han K.; Lv H.; Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett 2015,10(1),291-296","journal-title":"Oncol Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","volume":"52","author":"Kallen A.N.","year":"2013","unstructured":"Kallen A.N.; Zhou X.B.; Xu J.; Qiao C.; Ma J.; Yan L.; Lu L.; Liu C.; Yi J.S.; Zhang H.; Min W.; Bennett A.M.; Gregory R.I.; Ding Y.; Huang Y.; The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013,52(1),101-112","journal-title":"Mol Cell"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3390\/ijms14024298","volume":"14","author":"Matouk I.","year":"2013","unstructured":"Matouk I.; Raveh E.; Ohana P.; Lail R.A.; Gershtain E.; Gilon M.; De Groot N.; Czerniak A.; Hochberg A.; The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention. Int J Mol Sci 2013,14(2),4298-4316","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1261\/rna.351707","volume":"13","author":"Cai X.","year":"2007","unstructured":"Cai X.; Cullen B.R.; The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007,13(3),313-316","journal-title":"RNA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7150\/jca.21347","volume":"9","author":"Ma L.","year":"2018","unstructured":"Ma L.; Tian X.; Guo H.; Zhang Z.; Du C.; Wang F.; Xie X.; Gao H.; Zhuang Y.; Kornmann M.; Gao H.; Yang Y.; Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma. J Cancer 2018,9(2),389-399","journal-title":"J Cancer"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3892\/ol.2018.8788","volume":"16","author":"Zhu X.","year":"2018","unstructured":"Zhu X.; Li W.; Zhang R.; Liu Y.; MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1. Oncol Lett 2018,16(1),1298-1304","journal-title":"Oncol Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8244","DOI":"10.3892\/mmr.2018.8894","volume":"17","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Li Q.; Guo L.; MicroRNA-122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K\/AKT signaling in nasopharyngeal carcinoma in vitro. Mol Med Rep 2018,17(6),8244-8252","journal-title":"Mol Med Rep"},{"key":"ref=26","first-page":"3586","volume":"9","author":"Qu R.","year":"2017","unstructured":"Qu R.; Sun Y.; Li Y.; Hu C.; Shi G.; Tang Y.; Guo D.; MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12. Am J Transl Res 2017,9(8),3586-3598","journal-title":"Am J Transl Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.2147\/OTT.S135664","volume":"10","author":"Wu M.","year":"2017","unstructured":"Wu M.; Ye X.; Wang S.; Li Q.; Lai Y.; Yi Y.; MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2. OncoTargets Ther 2017,10,2815-2822","journal-title":"OncoTargets Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1139\/bcb-2016-0237","volume":"95","author":"Yan L.","year":"2017","unstructured":"Yan L.; Cai K.; Liang J.; Liu H.; Liu Y.; Gui J.; Interaction between miR-572 and PPP2R2C, and their effects on the proliferation, migration, and invasion of nasopharyngeal carcinoma (NPC) cells. Biochem Cell Biol 2017,95(5),578-584","journal-title":"Biochem Cell Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2147\/OTT.S126781","volume":"10","author":"Wang J.G.","year":"2017","unstructured":"Wang J.G.; Tang W.P.; Liao M.C.; Liu Y.P.; Ai X.H.; MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1. OncoTargets Ther 2017,10,753-761","journal-title":"OncoTargets Ther"},{"key":"ref=30","first-page":"1219","volume":"30","author":"Zhao J.C.","year":"2016","unstructured":"Zhao J.C.; Shi Y.; Zhang Y.; Zhang X.; Ma X.; Jia Z.H.; Wu Z.J.; Zhang J.Q.; [The expression of MiR-148a in nasopharyngeal carcinoma and its effect on tumor cell biology functions in nasopharyngeal carcinoma]  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016,30(15),1219-1223","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"54838","DOI":"10.18632\/oncotarget.10761","volume":"7","author":"Li H.","year":"2016","unstructured":"Li H.; Li X.; Ge X.; Jia L.; Zhang Z.; Fang R.; Yang J.; Liu J.; Peng S.; Zhou M.; Xiang J.; Zeng Z.; Zhou W.; Xiong W.; Xiao G.; Fang L.; Li G.Y.; Li Z.; MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A. Oncotarget 2016,7(34),54838-54851","journal-title":"Oncotarget"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.18632\/oncotarget.6504","volume":"7","author":"He Q.","year":"2016","unstructured":"He Q.; Ren X.; Chen J.; Li Y.; Tang X.; Wen X.; Yang X.; Zhang J.; Wang Y.; Ma J.; Liu N.; miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K\/AKT and MAPK signaling pathways. Oncotarget 2016,7(3),3047-3058","journal-title":"Oncotarget"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/cbf.3152","volume":"33","author":"Lv L.Y.","year":"2015","unstructured":"Lv L.Y.; Wang Y.Z.; Zhang Q.; Zang H.R.; Wang X.J.; miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4. Cell Biochem Funct 2015,33(8),534-540","journal-title":"Cell Biochem Funct"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/ijmm.2015.2245","volume":"36","author":"Pan X.","year":"2015","unstructured":"Pan X.; Peng G.; Liu S.; Sun Z.; Zou Z.; Wu G.; MicroRNA-4649-3p inhibits cell proliferation by targeting protein tyrosine phosphatase SHP-1 in nasopharyngeal carcinoma cells. Int J Mol Med 2015,36(2),559-564","journal-title":"Int J Mol Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12885-015-1464-x","volume":"15","author":"Yang W.","year":"2015","unstructured":"Yang W.; Lan X.; Li D.; Li T.; Lu S.; MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells. BMC Cancer 2015,15,461","journal-title":"BMC Cancer"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.12659\/MSM.898110","volume":"22","author":"Huang S.","year":"2016","unstructured":"Huang S.; Li X.; Zhu H.; MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells. Med Sci Monit 2016,22,4330-4337","journal-title":"Med Sci Monit"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1002\/cam4.863","volume":"5","author":"Chen C.","year":"2016","unstructured":"Chen C.; Lu Z.; Yang J.; Hao W.; Qin Y.; Wang H.; Xie C.; Xie R.; MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21. Cancer Med 2016,5(12),3489-3499","journal-title":"Cancer Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jbt.21827","volume":"30","author":"Yan H.L.","year":"2016","unstructured":"Yan H.L.; Li L.; Li S.J.; Zhang H.S.; Xu W.; miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1. J Biochem Mol Toxicol 2016,30(12),602-607","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"7e2156","DOI":"10.1038\/cddis.2016.64","author":"Liu Y.","year":"2016","unstructured":"Liu Y.; Zhao R.; Wang H.; Luo Y.; Wang X.; Niu W.; Zhou Y.; Wen Q.; Fan S.; Li X.; Xiong W.; Ma J.; Li X.; Tan M.; Li G.; Zhou M.;  miR-141 is involved in BRD7-mediated cell proliferation\n\tand tumor formation through suppression of the\n\tPTEN\/AKT pathway in nasopharyngeal carcinoma. Cell Death\n\tDis.,  2016,7e2156"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092810","volume":"19","author":"Sun L.","year":"2018","unstructured":"Sun L.; Meckes D.G.; Jr Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein(-)Barr Virus-Associated Cancers. Int J Mol Sci 2018,19(9)","journal-title":"Int J Mol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1002\/hed.25544","author":"Gao W.","year":"2018","unstructured":"Gao W.; Wong T.S.; Lv K.X.; Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Head Neck 2018","journal-title":"Head Neck"},{"key":"ref=42","first-page":"6387","author":"Matouk I.J.","year":"2015","unstructured":"Matouk I.J.; Halle D.; Raveh E.; The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget 2015,6387","journal-title":"Oncotarget"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.humpath.2017.09.006","volume":"69","author":"Zheng Y.","year":"2017","unstructured":"Zheng Y.; Lu X.; Xu L.; Chen Z.; Li Q.; Yuan J.; MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1. Hum Pathol 2017,69,63-71","journal-title":"Hum Pathol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"29209","DOI":"10.18632\/oncotarget.4976","volume":"6","author":"Vennin C.","year":"2015","unstructured":"Vennin C.; Spruyt N.; Dahmani F.; Julien S.; Bertucci F.; Finetti P.; Chassat T.; Bourette R.P.; Le Bourhis X.; Adriaenssens E.; H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget 2015,6(30),29209-29223","journal-title":"Oncotarget"},{"key":"ref=45","first-page":"11195","volume":"8","author":"Zhai L.L.","year":"2015","unstructured":"Zhai L.L.; Wang P.; Zhou L.Y.; Yin J.Y.; Tang Q.; Zhang T.J.; Wang Y.X.; Yang D.Q.; Lin J.; Deng Z.Q.; Over-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients. Int J Clin Exp Med 2015,8(7),11195-11201","journal-title":"Int J Clin Exp Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2013.12.126","volume":"448","author":"Zhuang M.","year":"2014","unstructured":"Zhuang M.; Gao W.; Xu J.; Wang P.; Shu Y.; The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014,448(3),315-322","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00109-018-1687-9","volume":"96","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Meng Q.; Wang C.; Li X.; Lu Y.; Xin X.; Zheng Q.; Lu D.; MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells. J Mol Med (Berl) 2018,96(10),1119-1130","journal-title":"J Mol Med (Berl)"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12943-015-0342-0","volume":"14","author":"He D.","year":"2015","unstructured":"He D.; Wang J.; Zhang C.; Shan B.; Deng X.; Li B.; Zhou Y.; Chen W.; Hong J.; Gao Y.; Chen Z.; Duan C.; Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol Cancer 2015,14,73","journal-title":"Mol Cancer"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1002\/stem.2225","volume":"33","author":"Huang Y.","year":"2015","unstructured":"Huang Y.; Zheng Y.; Jia L.; Li W.; Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-\u03b21\/Smad3\/HDAC Signaling Pathway by Deriving miR-675. Stem Cells 2015,33(12),3481-3492","journal-title":"Stem Cells"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1111\/febs.12902","volume":"281","author":"Zhu M.","year":"2014","unstructured":"Zhu M.; Chen Q.; Liu X.; Sun Q.; Zhao X.; Deng R.; Wang Y.; Huang J.; Xu M.; Yan J.; Yu J.; lncRNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J 2014,281(16),3766-3775","journal-title":"FEBS J"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:56:46Z","timestamp":1746572206000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173651\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467212666190719120446","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}